4 Ways This Revolutionary Gene-Editing Tool Could Change the World
Recombinetics and its subsidiaries are working on #1, #2, and #3 in this NBC News article on CRISPR.
Gene Editing Market Outlook: Biotech & Pharma to be the Leading End-User
https://gminsights.wordpress.com/2017/02/09/gene-editing-market/
Recombinetics Awarded NIH Grant to Develop a Humanized Swine Model of Alzheimer’s Disease
ST. PAUL, MINNESOTA – Recombinetics, a global biotechnology leader in gene editing of livestock for human therapeutics and food production applications, has been awarded a $358,338 Phase I Small Business Innovative Research (SBIR) grant from the National Institute on Aging, National Institutes of Health (NIH) to create a genetically accurate [...]
Recombinetics Expands Senior Management Team with Industry Veterans in Agriculture and Biomedicine
Gene-editing leader adds top talent to commercialize rapid growth business lines ST. PAUL, MN. Recombinetics (Recombinetics.com), a St. Paul-based global leader in gene-editing of livestock for food production and human therapeutic applications, is pleased to announce the hiring of Tom Erdmann as General Manager of its agriculture business Acceligen (Acceligen.com), and [...]
